DTC Pros and Cons Presented at FDA Hearing
This article summarizes the main points, both pro and con, made by presenters at recent FDA hearing on DTC and includes commentary from expert members of the Pharms Marketing Roundtable, which met to discuss the issues raised at this hearing.
Pharma Marketing News Vol. 4, #10
Vol. 4, No. 10: November 2005 Welcome to the November, 2005 issue of Pharma Marketing News. Subscribe...
DTC Regulation: Trick or Treat?
At a post-Halloween public hearing this week, the FDA will be soliciting public commentary about several direct-to-consumer (DTC) advertising techniques employed by pharmaceutical marketers....
Tobacco & Drugs: Strange Bedfellows
Quick! What does the tobacco industry and drug industry have in common?Yes, they are both among the most distrusted industries in the US today....
Target NPs and PAs Through Effective Sales and Marketing Strategies
Capitalize on the Fastest Growing Prescriber Group by Elevating Relationships, Building Brand Loyalty and Implementing Strategic Sampling Strategies.
Pitts on DTC and Older Americans
Peter Pitts, senior vice president of global health affairs at Manning Selvage & Lee (a PR firm with many pharmaceutical clients), former FDA Associate...
The Empire Strikes Back
Mike Pucci, Vice President of External Affairs at GlaxoSmithKline, is a man with a mission, which is to get the word out about the...
PhRMA’s Terrorist Plot
Back in May I posted a few comments about the Pharmaceutical Research and Manufacturers of America (PhRMA) commissioning Guiliani Partners to produce a report...
8th Original Forum on Customer Relationship Management (CRM) for the Bio/Pharmaceutical Industry
The 2005 forum brings together industry experts to share actual experiences and case studies on their challenges and successes in developing a customer focused strategy.
Cut Marketing, Raise Sales
As pharmaceutical companies post their quarterly earnings, I see that some major pharma companies have done better than others at increasing their sales and...
